Stay updated on DS-8201a in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS-8201a in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for DESTINY-Breast02 is displayed, describing a completed Phase 3 comparison of trastuzumab deruxtecan with standard treatment for previously treated HER2-positive advanced breast cancer. It also includes eligibility details, study outcomes, results-related publications, and information about data sharing.
    Difference
    100%
    Check dated 2026-11-11T20:34:50.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-28T21:00:46.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T21:53:38.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-14T22:01:15.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-07T22:10:18.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study details with an error page and site footer. This prevents users from viewing the trial information for the DESTINY-Breast02 study.
    Difference
    17%
    Check dated 2026-09-23T21:50:04.000Z thumbnail image

Stay in the know with updates to DS-8201a in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2+ Breast Cancer Clinical Trial page.